HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012) [PDF]
Publications are often used as a measure of research work success. Human T-lymphotropic virus (HTLV) type 1 and 2 are human retroviruses, which were discovered in the early 1980s, and it is estimated that 15-20 million people are infected worldwide. This
Gregorio GONZÁLEZ-ALCAIDE +4 more
doaj +6 more sources
Functional analysis of human T lymphotropic virus type 2 Tax proteins [PDF]
Background The Tax proteins encoded by human T lymphotropic virus type 1 (HTLV-1) and type 2 (HTLV-2) are transcriptional activators of both the viral long terminal repeat (LTR) and cellular promoters via the CREB and NFkB pathways. In contrast to HTLV-1,
Gautier Virginie +5 more
doaj +3 more sources
Human T-Lymphotropic Virus-1/2 Infection in Central Brazil Prisons: A Multicenter Study [PDF]
Human T-lymphotropic virus (HTLV) infection is endemic in some group populations. Prisoners are at high risk of acquiring HTLV infection mainly due to the environment of closed penal institutions, socioeconomic conditions, and risk behaviors.
Larissa Melo Bandeira +8 more
doaj +3 more sources
Work-Related Human T-lymphotropic Virus 1 and 2 (HTLV-1/2) Infection: A Systematic Review [PDF]
Human T-lymphotropic virus 1 and 2 (HTLV-1/2) belong to the delta group of retroviruses which may cause a life-long infection in humans, HTLV-1 leading to adult T-cell leukemia/lymphoma and other diseases. Different transmission modes have been described,
Angela Stufano +6 more
doaj +4 more sources
Provirus mutations of human T-lymphotropic virus 1 (HTLV-1), mostly the lack of the 5′ long terminal repeat (LTR) genomic region, have been described and associated with severe adult T cell leukemia/lymphoma (ATLL), non-sense point mutations with low ...
Karoline Rodrigues Campos +1 more
doaj +3 more sources
Objectives: This study was aimed at determining human T-lymphotropic virus 1/2 prevalence among apparently healthy, immunocompromised and haematologic malignant individuals in Nigeria’s capital, as well as meta-analysis of all Nigerian studies until date.
Nneoma Confidence JeanStephanie Anyanwu +5 more
doaj +3 more sources
Human T-lymphotropic virus 2 (HTLV-2) prevalence of blood donors in the state of Pará, Brazil. [PDF]
The present study had the objective to describe the molecular prevalence and epidemiological aspects of the human T-lymphotropic virus 2 (HTLV-2) infection in the blood donor population of the Pará state.The present study is a descriptive, retrospective, and cross-sectional review of epidemiological, serological, and molecular data on inapt blood ...
Correa LP +4 more
europepmc +3 more sources
Human T lymphotropic virus types 1 and 2: a point of view [PDF]
Reported at the beginning of the 1980s, Human T lymphotropic viruses type 1 and 2 (HTLV1, HTLV 2) were the first retroviruses to have been detected in human beings. HTLV 1 was isolated from adult T-cell leukemia (ATL) and first described by Takatsuki et al. in Japan in 1976, as a malignancy that only affects T cells and only in adults(1, 2).
Angela Cristina Malheiros Luzo
doaj +3 more sources
HTLV-1 and HTLV-2 Seroprevalence among Milk Donors in Shiraz, Southern Iran: A Letter to the Editor [PDF]
Navid Omidifar +8 more
doaj +2 more sources
Clinical Outcome in Human T-Lymphotropic Virus Type 2 Carriers Following Organ Transplantation [PDF]
Frequent and rapid development of myelopathy has been reported in individuals with human T-lymphotropic virus type 1 (HTLV-1) infection following solid organ transplantation. There is no information regarding HTLV-2, a closely related virus that often infects injection drug users.This study includes a retrospective analysis of all consecutive organ ...
Rafael Benito +3 more
openaire +4 more sources

